New microsoft word document

Dr. Sokka all publications 1997 – 2010

2010

167. Gender, body mass index and rheumatoid arthritis disease activity:
results from the QUEST-RA Study. Jawaheer D, Olsen J, Lahiff M, Forsberg
S, Lähteenmäki J, da Silveira IG, Rocha FA, Magalhães Laurindo IM,
Henrique da Mota LM, Drosos AA, Murphy E, Sheehy C, Quirke E, Cutolo M,
Rexhepi S, Dadoniene J, Verstappen SM, Sokka T. Clin Exp Rheumatol. 2010
Jul-Aug;28(4):454-61.
166. Remission makes its way to rheumatology. Sokka T, Mäkinen H.
Arthritis Res Ther. 2010 Jul 14;12(4):129.
165. Lipoprotein subclasses determined by nuclear magnetic resonance
spectroscopy and coronary atherosclerosis in patients with rheumatoid
arthritis. Chung CP, Oeser A, Raggi P, Sokka T, Pincus T, Solus JF, Linton
MF, Fazio S, Stein CM. J Rheumatol. 2010 Aug 1;37(8):1633-8.
164. How should rheumatoid arthritis disease activity be measured today
and in the future in clinical care? Sokka T. Rheum Dis Clin North Am. 2010
May;36(2):243-57.
163. Current evidence for a strategic approach to the management of
rheumatoid arthritis with disease-modifying antirheumatic drugs: a
systematic literature review informing the EULAR recommendations for the
management of rheumatoid arthritis. Knevel R, Schoels M, Huizinga TW,
Aletaha D, Burmester GR, Combe B, Landewé RB, Smolen JS, Sokka T, van der
Heijde DM. Ann Rheum Dis. 2010 Jun;69(6):987-94.
162. EULAR recommendations for the management of rheumatoid arthritis with
synthetic and biological disease-modifying antirheumatic drugs. Smolen JS,
Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S,
Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T,
Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J,
Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P,
Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL,
Wong J, Zink A, van der Heijde D. Ann Rheum Dis. 2010 Jun;69(6):964-75.
161. Work disability remains a major problem in rheumatoid arthritis in
the 2000s: data from 32 countries in the QUEST-RA Study. Sokka T,
Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R, Andersone D,
Badsha H, Baecklund E, Belmonte M, Craig-Müller J, da Mota LM, Dimic A,
Fathi NA, Ferraccioli G, Fukuda W, Géher P, Gogus F, Hajjaj-Hassouni N,
Hamoud H, Haugeberg G, Henrohn D, Horslev-Petersen K, Ionescu R, Karateew
D, Kuuse R, Laurindo IM, Lazovskis J, Luukkainen R, Mofti A, Murphy E,
Nakajima A, Oyoo O, Pandya SC, Pohl C, Predeteanu D, Rexhepi M, Rexhepi S,
Sharma B, Shono E, Sibilia J, Sierakowski S, Skopouli FN, Stropuviene S,
Toloza S, Valter I, Woolf A, Yamanaka H; the QUEST-RA study group.
Arthritis Res Ther. 2010 Mar 12;12(2):R42. [Epub ahead of print]
160. Treating rheumatoid arthritis to target: recommendations of an
international task force. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC,
Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P,
Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK,
McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T
Expert Committee. Ann Rheum Dis. 2010 Apr;69(4):631-7. Epub 2010 Mar 9.
159. Supervised machine learning and logistic regression identifies novel
epistatic risk factors with PTPN22 for rheumatoid arthritis. Briggs FB,
Ramsay PP, Madden E, Norris JM, Holers VM, Mikuls TR, Sokka T, Seldin MF,
Gregersen PK, Criswell LA, Barcellos LF. Genes Immun. 2010
2009

158. Mäkinen H, Sokka T: Nivelreuman aktiivisuusmittareiden hyödyntäminen
potilaan hoidossa. Suomen Lääkärilehti 2009:64; 2183-86.
157. Häkkinen A, Arkela-Kautiainen M, Sokka T, Hannonen P, Kautiainen H.
Self-report functioning according to the ICF model in elderly patients
with rheumatoid arthritis and in population controls using the
multidimensional health assessment questionnaire. J Rheumatol. 2009
Feb;36(2):246-53.
156. Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T, Pincus T,
Raggi P, Gebretsadik T, Shintani A, Stein CM. Inflammatory mediators and
premature coronary atherosclerosis in rheumatoid arthritis. Arthritis
Rheum. 2009 Nov 15;61(11):1580-5.
155. Sokka T, Pincus T. Joint counts to assess rheumatoid arthritis for
clinical research and usual clinical care: advantages and limitations.
Rheum Dis Clin North Am. 2009 Nov;35(4):713-22, v-vi.
154. Pincus T, Yazici Y, Sokka T. Complexities in assessment of rheumatoid
arthritis: absence of a single gold standard measure. Rheum Dis Clin North
Am. 2009 Nov;35(4):687-97, v.
153. Pincus T, Callahan LF, Sokka T. A Standard Protocol to Evaluate
Rheumatoid Arthritis (SPERA) for efficient capture of essential data from
a patient and a health professional in a uniform "scientific" format.
Rheum Dis Clin North Am. 2009 Nov;35(4):843-50, xi.
152. Pincus T, Sokka T. Laboratory tests to assess patients with
rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am.
2009 Nov;35(4):731-4, vi-vii.
151. Yazici Y, Sokka T, Pincus T. Radiographic measures to assess patients
with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin
North Am. 2009 Nov;35(4):723-9, vi.
150. Sokka T. Influence of gender on the symptoms and severity of
rheumatoid arthritis: do women suffer more? Int J Clin Rheumatol
2009;4(3):245-247.
149. Khan NA, Yazici Y, Calvo-Alen J, Dadoniene J, Gossec L, Hansen TM,
Huisman M, Kallikorm R, Muller R, Liveborn M, Oding R, Luchikhina E,
Naranjo A, Rexhepi S, Taylor P, Tlustochowich W, Tsirogianni A, Sokka T.
Reevaluation of the Role of Duration of Morning Stiffness in the
Assessment of Rheumatoid Arthritis Activity. J Rheumatol. 2009 Oct 15.
[Epub ahead of print]
148. Liu Z, Sokka T, Maas K, Olsen N, Aune TM. Prediction of Disease
Severity in Patients with Early Rheumatoid Arthritis by Gene Expression
Profiling. Human Genomics and Proteomics, vol 2009, Article ID 484351, 10
pages, 2009. doi:10.4061/2009/484351
147. Pincus T, Swearingen CJ, Luta G, Sokka T. Efficacy of prednisone 1-4
mg/day in patients with rheumatoid arthritis: a randomised, double-blind,
placebo controlled withdrawal clinical trial. Ann Rheum Dis. 2009
Nov;68(11):1715-20. Epub 2008 Dec 15.
146. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, Carmona L, Daurès JP, de Wit M, Dijkmans BA, Englbrecht M, Gunendi Z, Heiberg T, Kirwan JR, Mola EM, Matucci-Cerinic M, Otsa K, Schett G, Sokka T, Wells GA, Aanerud GJ, Celano A, Dudkin A, Hernandez C, Koutsogianni K, Akca FN, Petre AM, Richards P, Scholte-Voshaar M, Von Krause G, Kvien TK. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis. 2009 Nov;68(11):1680-5. Epub 2008 Dec 3. 145. Sokka T, Pincus T. Rheumatoid arthritis: strategy more important than agent. Lancet 2009; 374 August 8:430-2 (Comment). 144. Palindromic Rheumatism: Longterm Outcomes of 60 Patients Diagnosed 1967-84. Koskinen E, Hannonen P, Sokka T. J Rheumatol. 2009 Jul 31. [Epub ahead of print] 143. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Sokka T, Kautiainen H, Pincus T, Toloza S, Castelar Pinheiro GD, Lazovskis J, Hetland ML, Peets T, Immonen K, Maillefert JF, Drosos AA, Alten R, Pohl C, Rojkovich B, Bresnihan B, Minnock P, Cazzato M, Bombardieri, Rexhepi S, Rexhepi M, Andersone D, Stropuviene S, Huisman M, Sierakowski S, Karateev D, Skakic V, Naranjo A, Baecklund E, Henrohn D, Gogus F, Badsha H, Taylor P, McClinton C, Yazici Y. Ann Rheum Dis. 2009 Nov;68(11):1666-72. Epub 2009 Jul 30. 142. An excellent example of an early arthritis clinic -- what is its clinical value? Sokka T, Mäkinen H. J Rheumatol. 2009 Jul;36(7):1355-6. 141. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM. Arthritis Rheum. 2009 Jun 29;60(7):1906-1914. 140. Declines in Erythrocyte Sedimentation Rates in Patients with Rheumatoid Arthritis Over the Second Half of the 20th Century. Abelson B, Sokka T, Pincus T. J Rheumatol. 2009 Jun 16. [Epub ahead of print] 139. Pincus T, Sokka T. "Keep It Simple Stupid": MDHAQ function, Pain, Global, and RAPID3 Quantitative Scores to Improve and Document Quality of Rheumatologic Care. J Rheumatol. 2009 Jun;36(6):1099-100. 138. Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF, Kastner DL, Seldin MF, Criswell LA, Plenge RM, Holers VM, Mikuls TR, Sokka T, Moreland LW, Bridges SL Jr, Xie G, Begovich AB, Siminovitch KA. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet. 2009 Jun 7. [Epub ahead of print] 137. Erythrocyte Sedimentation Rate, C-Reactive Protein, or Rheumatoid Factor Are Normal at Presentation in 35%-45% of Patients with Rheumatoid Arthritis Seen Between 1980 and 2004: Analyses from Finland and the United States. Sokka T, Pincus T. J Rheumatol. 2009 Jul; 36(7):1387-90. 136. Long-term outcomes of rheumatoid arthritis. Sokka T. Curr Opin Rheumatol. 2009 May; 21(3):284-90. 135. Drug management of early rheumatoid arthritis - 2008. Sokka T, Mäkinen H. Best Pract Res Clin Rheumatol. 2009 Feb;23(1):93-102. Review. PMID: 19233049 [PubMed - indexed for MEDLINE]. 134. Women, men, and rheumatoid arthritis: analyses of disease activity,
disease characteristics, and treatments in the QUEST-RA Study. Sokka T,
Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H,
Peets T, Baranauskaite A, Géher P, Ujfalussy I, Skopouli FN, Mavrommati M,
Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W,
Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS,
Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro GD, Karateev D, Andersone
D, Rexhepi S, Yazici Y, Pincus T; the QUEST-RA Group. Arthritis Res Ther.
2009 Jan 14;11(1):R7.
2008

133. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008
update. Clin Exp Rheumatol 2008; 26(Suppl.51):S35-S61.
132. Sokka T, Hakkinen A. Poor physical fitness and performance as
predictors of mortality in normal populations and patients with rheumatic
and other diseases. Clin Exp Rheumatol 2008; 26(Suppl.51):S14-S20.
131. Pincus T, Sokka T. Should an order to “monitor long-term vital
signs”, including mortality outcomes, be as routine as an order of a
laboratory test in patients with rheumatic diseases? Clin Exp Rheumatol
2008; 26(Suppl.51):S21-S24.
130. Pincus T, Sokka T. Mortality in rheumatic diseases: Introduction.
Clin Exp Rheumatol 2008; 26(Suppl.51):S1-S4.
129. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C,
Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J,
Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K,
O'Dell J, Paulus H, Pincus T, Richards P, Simon L, Siegel J, Smolen JS,
Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van
Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B,
Zink A, Felson D. Reporting disease activity in clinical trials of
patients with rheumatoid arthritis: EULAR/ACR collaborative
recommendations. Arthritis Rheum 2008 Oct 15;59(10):1371-7.
128. Methods of deriving EULAR/ACR recommendations on reporting disease
activity in clinical trials of patients with rheumatoid arthritis.
Karonitsch T, Aletaha D, Boers M, Bombardieri S, Combe B, Dougados M,
Emery P, Felson D, Gomez-Reino J, Keystone E, Kvien TK, Martin-Mola E,
Matucci-Cerinic M, Richards P, van Riel P, Siegel J, Smolen JS, Sokka T,
van der Heijde D, van Vollenhoven R, Ward M, Wells G, Zink A, Landewe R.
Ann Rheum Dis. 2008 Oct;67(10):1365-73.
127. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C,
Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J,
Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K,
O'Dell J, Paulus H, Pincus T, Richards P, Simon L, Siegel J, Smolen JS,
Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van
Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B,
Zink A, Felson D. Reporting disease activity in clinical trials of
patients with rheumatoid arthritis: EULAR/ACR collaborative
recommendations. Ann Rheum Dis. 2008 Oct;67(10):1360-4.2008
126. Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A,
Raggi P, Sokka T, Pincus T, Stein CM. Amino-terminal fragment of the
prohormone brain-type natriuretic peptide in rheumatoid arthritis.
Arthritis Rheum. 2008 Aug 29;58(9):2662-2669.
125. Sokka T, Hetland ML, Mäkinen H, Kautiainen H, Hørslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli GF, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimic A, Nedovic J, Stankovic A, Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group. Remission and Rheumatoid Arhtiritis. Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008; 58: 2642-51. 124. Sokka T, Pincus T. Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United States. Rheumatology (Oxford). 2008 Oct;47(10):1543-7. Epub 2008 Aug 7. 123. Mäkinen H, Kautiainen H, Hannonen P, Sokka T. A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA). J Rheumatol. 2008 Aug;35(8):1522-7. 122. Pincus T, Bergman M, Sokka T, Roth J, Swearingen C, Yazici Y. Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J Rheumatol. 2008 Aug;35(8):1550-8. 121. Sokka T. Northern highlights in rheumatology. Future Rheumatol 2008;3(2):121-6. 120. Hakkinen A, Makinen H, Ylinen J, Hannonen P, Sokka T, Neva M, Kautiainen H, Kauppi M. Stability of the upper neck during isometric neck exercises in rheumatoid arthritis patients with atlantoaxial disorders. Scand J Rheumatol. 2008 Sep - Oct; 37(5): 343-7. 119. Pincus T, Sokka T. Quantitative clinical assessment in busy rheumatology settings: The value of short patient questionnaires. J Rheumatol 2008;35:1235-7 118. Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Avalos I, Sokka T, Pincus T, Raggi, P, Stein CM. Inflammation-associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008 Jun 24;58(7):2105-2112. 117. Mäkinen H, Hannonen P, Sokka T. Sex: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis? Ann Rheum Dis 2008;67:1052-3 116. Sokka T. Radiographic Scoring in Rheumatoid Arthritis. A Short Introduction to the Methods. Bulletin of the NYU Hospital for Joint Diseases 2008;66(2):166-8 115. Pincus T, Yazici Y, Sokka T. Are excellent systematic reviews of clinical trials useful for patient care? Nat Clin Pract Rheumatol. 2008 Jun;4(6):294-5. Epub 2008 May 6. 114. Sokka T, Envalds M, Pincus T. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol. 2008;18(3):228-39. 113. Naranjo A, Sokka T, Descalzo MA, Calvo-Alen J, Horslev-Petersen K, Luukkainen RK, Combe B, Burmester GR, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Tunc R, Dimic A, Bergman M, Toloza S, Pincus T. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008 Mar 6;10(2):R30. 112. Sokka T, Häkkinen A, Kautiainen H, Maillefert JF, Toloza S, Mørk
Hansen T, Calvo-Alen J, Oding R, Liveborn M, Huisman M, Alten R, Pohl C,
Cutolo M, Immonen K, Woolf A, Murphy E, Sheehy C, Quirke E, Celik S,
Yazici Y, Tlustochowicz W, Kapolka D, Skakic V, Rojkovich B, Müller R,
Stropuviene S, Andersone D, Drosos AA, Lazovskis J, Pincus T; QUEST-RA
Group. Physical inactivity in patients with rheumatoid arthritis: data
from twenty-one countries in a cross-sectional, international study.
Arthritis Rheum. 2008 Jan 15;59(1):42-50.
2007

111. Sokka T. Is the long-term outcome of rheumatoid arthritis improving?
Evidence from total joint replacement surgery. Future Rheumatol
2007:2;237-9.
110. Avalos I, Chung CP, Oeser A, Gebretsadik T, Shintani A, Kurnik D,
Raggi P, Sokka T, Pincus T, Stein CM. Increased Augmentation Index in
Rheumatoid Arthritis and Its Relationship to Coronary Artery
Atherosclerosis. J Rheumatol. 2007 Dec;34(12):2388-2394. Epub 2007 Nov 15.
109. Sokka T, Haugeberg G, Pincus T. Assessment of quality of rheumatoid
arthritis care requires joint count and/or patient questionnaire data not
found in a usual medical record: examples from studies of premature
mortality, changes in clinical status between 1985 and 2000, and a
QUEST-RA global perspective. Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl
47):86-97.
108. Verstappen SM, Jacobs JW, Huisman AM, van Rijthoven AW, Sokka T,
Bijlsma JW. Functional Health Assessment Questionnaire (HAQ) and
Psychological HAQ Are Associated with and Predicted by Different Factors
in Rheumatoid Arthritis. J Rheumatol. 2007 Sep;34(9):1837-40. Epub 2007
Aug 1.
107. Pincus T, Sokka T. Can a Multi-Dimensional Health Assessment
Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID)
scores be informative in patients with all rheumatic diseases?
Best Pract Res Clin Rheumatol. 2007 Aug;21(4):733-53.
106. Pincus T, Sokka T. A three-page Standard Protocol to Evaluate
Rheumatoid Arthritis (SPERA) for efficient capture of essential data from
patients and health professionals in standard clinical care and clinical
research. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):677-85.
105. Sokka T. Quantitative assessment of rheumatoid arthritis in standard
clinical care: turning clinical care into clinical science. Best Pract Res
Clin Rheumatol. 2007 Aug;21(4):653-61.
104. Pincus T, Yazici Y, Sokka T. Quantitative measures of rheumatic
diseases for clinical research versus standard clinical care: differences,
advantages and limitations. Best Pract Res Clin Rheumatol. 2007
Aug;21(4):601-28.
103. Sokka T. Scandinavian registers in normal and arthritic populations.
Bull NYU Hosp Jt Dis. 2007;65(2):135-8. No abstract available.
102. Makinen H, Kautiainen H, Hannonen P, Mottonen T, Korpela M,
Leirisalo-Repo M, Luukkainen R, Puolakka K, Karjalainen A, Sokka T.
Disease Activity Score 28 as an Instrument to Measure Disease Activity in
Patients with Early Rheumatoid Arthritis. J Rheumatol. 2007 Jul 1; [Epub
ahead of print]
101. Asanuma Y, Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T,
Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Serum osteoprotegerin is
increased and independently associated with coronary-artery
atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis.
2007 Jun 12; [Epub ahead of print]
100. Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Hetland
ML, Nranjo A, Baecklund E, Herborn G, Rau R, Cazzato M, Gossec L, Skakic
V, Gogus F, Sierakowski S, Bresnihan B, Taylor P, McClinton C, Pincus T
for the QUEST-RA Group. QUEST-RA: Quantitative clinical assessment of
patients with rheumatoid arthritis seen in standard rheumatology care in
15 countries. Ann Rheum Dis. 2007 Apr 5; [Epub ahead of print].
99. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A,
Raggi P, Sokka T, Pincus T, Stein CM. Prevalence of the metabolic syndrome
is increased in rheumatoid arthritis and is associated with coronary
atherosclerosis. Atherosclerosis. 2007 Jan 29; [Epub ahead of print].
98. Sokka T, Makinen H, Hannonen P, Pincus T. Most people over age 50 in
the general population do not meet ACR remission criteria or OMERACT
minimal disease activity criteria for rheumatoid arthritis. Rheumatology,
2007.
97. Sokka T, Kautiainen H, Hannonen P. Stable occurrence of knee and hip
total joint replacement in Central Finland between 1986 and 2003: an
indication of improved long-term outcomes of rheumatoid arthritis. Ann
Rheum Dis. 2007 Mar;66(3):341-4. Epub 2006 Oct 26.
96. Yazici Y, Kautiainen H, Sokka T. Differences in clinical status
measures in different ethnic/racial groups with early rheumatoid
arthritis: implications for interpretation of clinical trial data. J
Rheumatol. 2007 Feb;34(2):311-5.
95. Mäkinen, Kautiainen, Hannonen, Möttönen, Leirisalo-Repo, Laasonen,
Korpela, Blåfield, Hakola, Sokka. Sustained Remission and Reduced
Radiographic Progression with Combination Disease Modifying Antirheumatic
Drugs in Early Rheumatoid Arthritis. J Rheumatol. 2007 Feb;34(2):316-321.
Epub 2006 Dec 15.
94. Sokka T. Self-reporting instruments in rheumatoid arthritis. Nat Clin
Pract Rheumatol. 2007 Feb;3(2):74-5. Epub 2007 Jan 16.
93. Luukkainen R, Sokka T, Kautiainen H, Hannonen P, Laasonen L,
Leirisalo-Repo M, Korpela M, Julkunen H, Puolakka K, Blåfield H, Kauppi M,
Möttönen T for the RIN-RACo group. The prognosis of 5-year radiographic
erosions of the wrist according to early, late, and persistent wrist
swelling or tenderness in patients with early rheumatoid arthritis. J
Rheumatol 2007 ;34(1):50-3.
2006

92. Pincus T, Sokka T. Quantitative measures to assess patients with
rheumatic diseases: 2006 update. Rheum Dis Clin North Am. 2006 Dec;32
Suppl 1:29-36.
91. Chung CP, Sokka T, Arbogast P, Pincus T. Work disability in rheumatoid
arthritis: differences in patients with early disease in Finland and the
United States. Ann Rheum Dis. 2006 Dec;65(12):1653-7. Epub 2006 Jun 1.
90. Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka
T, Pincus T, Stein CM. Utility of the Framingham Risk Score to Predict the
Presence of Coronary Atherosclerosis in Patients with Rheumatoid
Arthritis. Arthritis Res Ther. 2006 Dec 14;8(6):R186.
89. Makinen H, Hannonen P, Sokka T. Various definitions of remission for
rheumatoid arthritis and review of selected clinical cohorts and
randomized clinical trials for the rate of remission. Clin Exp Rheumatol.
2006 Nov-Dec;24(6 Suppl 43):S022-8.
88. Sokka T, Makinen H, Puolakka K, Mottonen T, Hanonen P. Remission as
the treatment goal – the FIN-RACo trial. Clin Exp Rheumatol. 2006
Nov-Dec;24(6 Suppl 43):S074-6.
87. Sokka T, Kautiainen H, Hannonen P, Pincus T. Changes in HAQ disability
scores over 5 years in patients with rheumatoid arthritis compared to the
general population. Arthritis Rheum 2006;54(10):3113-3118
86. Sokka T, Makinen H. Improving outcomes in rheumatoid: What determines
decisions to change ineffective therapy? J Rheumatol 2006;33:1213-5
(Editorial).
85. Pincus T, Sokka T, Chung C, Cawkwell G. Declines of tender and swollen
joint counts between 1985 and 2001 in patients with rheumatoid arthritis
seen in standard care: Possible considerations for revision of inclusion
criteria for clinical trials. Ann Rheum Dis. 2006 Jul;65(7):878-83. Epub
2005 Dec 8.
84. Neva MH, Häkkinen A, Mäkinen H, Kautiainen H, Hannonen P, Kauppi M,
Sokka T. High prevalence of asymptomatic cervical spine subluxations in
patients with rheumatoid arthritis waiting for orthopaedic surgery. Ann
Rheum Dis. 2006 Jul;65(7):884-8. Epub 2005 Nov 3.
83. Pincus T, Sokka T. Should aggressive therapy for rheumatoid arthritis
require early use of weekly low-dose methotrexate, as the first
disease-modifying anti-rheumatic drug in most patients? Rheumatology
2006;45:497-9. (Editorial)
82. Pincus T, Sokka T. Evidence-based practice and practice-based
evidence. Nat Clin Pract Rheumatol. 2006 Mar;2(3):114-5.
81. Häkkinen A, Kautiainen H, Hannonen P, Ylinen J, Mäkinen H, Sokka T.
Muscle strength, pain, and disease activity explain individual
subdimensions of the Health Assessment Questionnaire disability index,
especially in women with rheumatoid arthritis. Ann Rheum Dis. 2006
Jan;65(1):30-4. Epub 2005 May 18.
2005

80. Sokka T, Hannonen P, Mottonen T. Conventional disease-modifying
antirheumatic drugs in early arthritis. Rheum Dis Clin North Am. 2005
Nov;31(4):729-44.
79. Sokka T. Rheumatoid arthritis databases in Finland. Clin Exp Rheumatol
2005;23 (Suppl. 39): S201-S204
78. Sokka T, Pincus T. An early rheumatoid arthritis treatment evaluation
registry (ERATER) in the United States. Clin Exp Rheumatol 2005;23 (Suppl.
39): S178-S181
77. Sokka T. Assessment of pain in rheumatic diseases. Clin Exp Rheumatol
2005;23 (Suppl. 39): S77-S84
76. Sokka T. Quantitative joint assessment in rheumatoid arthritis. Clin
Exp Rheumatol 2005;23 (Suppl. 39): S58-S62
75. Pincus T, Sokka T. Complexities in the quantitative assessment of
patients with rheumatic diseases in clinical trials and clinical care.
Clin Exp Rheumatol 2005;23 (Suppl. 39): S1-S9
74. Chung C, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus
T, Avalos I, Stein CM. Increased coronary-artery atherosclerosis in
rheumatoid arthritis. Arthritis Rheum 2005;52:3045-53.
73. Häkkinen A, Neva MH, Kautiainen H, Kauppi M, Hannonen P, Ylinen J,
Mäkinen H, Jäppinen I, Sokka T. Decreased muscle strength and mobility of
the neck in patients with rheumatoid arthritis and atlantoaxial disorders.
Arch Phys Med Rehabil 2005 Aug;86(8):1603-8.
72. Pincus T, Sokka T, Kautiainen H. Further development of a physical
function scale on a multidimensional health assessment questionnaire
(MDHAQ) for standard care of patients with rheumatic diseases. J Rheumatol
2005;32:1432-9.
71. Vuorela J, Kauppinen T, Sokka T. Distribution of Radiation in
Synovectomy of the Knee with (166)Ho-FHMA Using Image Fusion. Cancer
Biother Radiopharm. 2005 Jun;20(3):333-7.
70. Mäkinen H, Kautiainen H, Hannonen P, Sokka T. Is DAS28 an appropriate
tool to assess remission in rheumatoid arthritis? Ann Rheum Dis.
2005;64:1410-3. doi:10.1136/ard.2005.037333
69. Mäkinen H, Kautiainen H, Hannonen P, Sokka T. Frequency of remissions
in early rheumatoid arthritis defined by three sets of criteria. A 5-year
follow-up study. J Rheumatol 2005;32:796-800.
68. Kauppi M, Sokka T, Hannonen P. Survey non-response is associated with
increased mortality in patients with rheumatoid arthritis and in community
population. J Rheumatol 2005;32:807-10.
67. Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid
arthritis care in 2000 have significantly better clinical status than
patients seen in 1985. Arthritis Rheum 2005;52:1009-19.
66. Krishnan E, Hakkinen A, Sokka T, Hannonen P. Impact of age and
comorbidities on the criteria for remission and response in rheumatoid
arthritis. Ann Rheum Dis. Mar 2005; 10.1136/ard.2005.037903.
65. Pincus T, Wang X, Chung C, Sokka T, Koch GG. Patient preference in a
crossover clinical trial of patients with osteoarthritis of the knee or
hip: Face validity of self-report questionnaire ratings. J Rheumatol
2005;32:533-9.
64. Pincus T, Sokka T. How aggressive should initial therapy for
rheumatoid arthritis be? Rheumatology 44:134-5, 2005. (Letter)
2004

63. Mäkinen H, Hannonen P, Sokka T. Rheumatoid arthritis patients waiting
for orthopedic surgery in Jyväskylä Central Hospital. Suomen Lääkärilehti
59:4623-6, 2004. (In Finnish)
62. Pincus T, Sokka T, Kavanaugh A. Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for “near remission” of DAS or single measures. Clin Exp Rheumatol (Suppl 35) S50-S56, 2004. 61. Pincus T, Sokka T, Kavanaugh A. Quantitative documentation of risk/benefit of new therapies for rheumatoid arthritis: Patient questionnaires as an optimal measure in standard care. Clin Exp Rheumatol 22 (Suppl 35) S26-S33, 2004. 60. Pincus T, Kavanaugh A, Sokka T. Benefit/risk of therapies for rheumatoid arthritis: Underestimation of the “side effects” or risks of RA leads to underestimation of the benefit/risk of therapies. Clin Exp Rheumatol 22 (Suppl 35):S2-S11, 2004. 59. Pincus T, Sokka T. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa? Ann Rheum Dis 63:Suppl 2:ii32ii39, 2004. 58. Pincus T, Sokka T. Quantitative measures and indices to assess rheumatoid arthritis in clinical trials and clinical care. Rheum Dis Clin North Am 30:725-51, 2004. 57. Pincus T, Sokka T. Clinical trials in rheumatic diseases: designs and limitations. Rheum Dis Clin North Am 30:701-24, 2004. 56. Sokka T, Krishnan E. National databases and rheumatology research II: the National Health and Nutrition Examination Surveys. Rheum Dis Clin North Am 30:869-79, 2004. 55. Sokka T. Rheumatoid arthritis databases. Rheum Dis Clin North Am 30:769-81. 54. Sokka T. National databases and rheumatology research I: longitudinal databases in Scandinavia. Rheum Dis Clin North Am 30:851-67, 2004. 53. Olsen NJ, Sokka T, Seehorn CL, Kraft B, Maas K, Moore JH, Aune TM. A Gene Expression Signature for Recent Onset Rheumatoid Arthritis in Peripheral Blood Mononuclear Cells. Ann Rheum Dis 63:1387-92, 2004. 52. Yazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol 31;1723-6, 2004. 51. Häkkinen A, Sokka, T, Kautiainen H, Kotaniemi A, Hannonen P. Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis. A five-year follow up study. Ann Rheum Dis 63;910-6, 2004. 50. Yazici Y, Sokka T, Kautiainen H, Swearingen C, Kulman I, Pincus T. Long-term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely due to laboratory abnormalities. Ann Rheum Dis 2005;64:207-11. doi:10.1136/ard.2004.023408. 49. Sokka T, Kautiainen H, Häkkinen A, Hannonen P. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years. J Rheumatol 31;1073-82, 2004. 48. Hakkinen A, Kautiainen H, Hannonen P, Ylinen J, Arkela-Kautiainen M,
Sokka T. Pain and joint mobility explain individual dimensions of the
Health Assessment Questionnaire (HAQ) disability index in patients with
rheumatoid arthritis. Ann Rheum Dis 2005;64:59-63. doi:
10.1136/ard.2003.019935
47. Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, Wolfe F,
Gibofsky A, Simon L, Zlotnick S, Fort J. Patient preference for Placebo,
Acetaminophen or Celecoxib Efficacy Studies (PACES): Two randomized
placebo-controlled cross-over clinical trials in patients with
osteoarthritis of the knee or hip. Ann Rheum Dis 63;931-9, 2004.
46. Sokka T, Häkkinen A, Krishnan E, Hannonen P. Similar prediction of
mortality by the health assessment questionnaire in patients with
rheumatoid arthritis and the general population. Ann Rheum Dis 63;494-7,
2004.
45. Krishnan E, Sokka T, Häkkinen A, Hubert H, Hannonen P. Normative
values for the Health Assessment Questionnaire Disability Index.
Benchmarking disability in the general population. Arthritis Rheum
50:953-60, 2004.
44. Häkkinen A, Sokka T, Hannonen P. A home based two-year strength
training period in early rheumatoid arthritis led to good long-term
compliance. A five-year follow-up. Arthritis Rheum 51:56-62, 2004.
43. Pincus T, Keysor J, Sokka T, Krishnan E, Callahan LF. Patient
questionnaires and formal education level as prospective predictors of
mortality over 10 years in 97% of 1,416 patients with rheumatoid arthritis
from 15 United States private practices. J Rheumatol 31:229-34, 2004.
42. Pincus T, Sokka T. Current treatment of rheumatoid arthritis. In:
Rakel RE, Bope ET, editors. Conn's Current Therapy. W.B. Saunders Company,
2004.
2003

41. Sokka T, Kautiainen H, Möttönen T, Hannonen P. Erosions develop rarely
in joints without clinically detectable inflammation in patients with
early rheumatoid arthritis. J Rheumatol 30:2580-4, 2003.
40. Smolen J, Sokka T, Pincus T. A proposed treatment algorithm for
rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative
data. Clin Exp Rheumatol 21 (Suppl 31): s209-s210, 2003.
39. Pincus T, Sokka T. Uniform databases in early arthritis: Specific
measures to complement classification criteria and indices of clinical
change. Clin Exp Rheumatol 21 (Suppl 31): s79-s88, 2003.
38. Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen J. Methotrexate as the
”anchor drug” for the treatment of early rheumatoid arthritis. Clin Exp
Rheumatol 21 (Suppl 31): s179-s185, 2003.
37. Sokka T, Willoughby J, Yazici Y, Pincus T. Databases of patients with
early rheumatoid arthritis in USA. Clin Exp Rheumatol 21 (Suppl 31):
s146-s153, 2003.
36. Sokka T, Pincus T. A historical perspectivee concerning
population-based and clinical studies of early arthritis and early
rheumatoid arthritis. Clin Exp Rheumatol 21 (Suppl 31): s5-s14, 2003.
35. Sokka T. Early rheumatoid arthritis in Finland. Clin Exp Rheumatol 21
(Suppl 31): s133-s137, 2003.
34. Sokka T. Work disability in early rheumatoid arthritis. Clin Exp
Rheumatol 21 (Suppl 31): s71-s74, 2003.
33. Pincus T, Sokka T. Quantitative measures to assess rheumatoid
arthritis in clinical trials and clinical care. Best Pract Res Clin
Rheumatol 17(5):753-81, 2003.
32. Neva MH, Isomäki P, Hannonen P, Kauppi M, Krisnhan E, Sokka T. Early
and extensive erosiveness in peripheral joints predicts atlantoaxial
subluxations in patients with rheumatoid arthritis. Arthritis Rheum
48:1808-1813, 2003.
31. Sokka T. Assessment of pain in patients with rheumatic diseases. Best
Practice & Research Clinical Rheumatology 17:427-449, 2003.
30. Sokka T, Pincus T. Most patients receiving routine care for rheumatoid
arthritis in 2001 did not meet inclusion criteria for most recent clinical
trials or American College of Rheumatology criteria for remission. J
Rheumatol 30:1138-1146, 2003.
29. Krishnan E, Sokka T, Hannonen P. Smoking-gender interaction and risk
for rheumatoid arthritis. Arthritis Res 5(3):R158-62, 2003.
28. Vuorela J, Sokka T, Pukkala E, Hannonen P. Does yttrium
radiosynovectomy increase the risk of cancer in patients with rheumatoid
arthritis? Ann Rheum Dis 62:251-253, 2003.
27. Häkkinen A, Sokka T, Lietsalmi AM, Kautiainen H, Hannonen P. Effects
of dynamic strength training on physical function, Valpar 9 Work Sample
Test and working capacity in patients with recent onset rheumatoid
arthritis. Arthritis Care Res 49:71-77, 2003.
26. Sokka T, Pincus T. Eligibility of patients in routine care for major
clinical trials of anti-tumor necrosis factor-? agents in rheumatoid
arthritis. Arthritis Rheum 48:313-318, 2003.
25. Sokka T, Krishnan E, Häkkinen A, Hannonen P. Functional disability in
rheumatoid arthritis patients compared with a community population in
Finland. Arthritis Rheum 48:59-63, 2003.
2002

24. Sokka T, Pincus T. Contemporary DMARDs in patients with recent onset
rheumatoid arthritis in a US private practice: Methotrexate as the anchor
drug in 90% and new DMARDs in 30% of patients. J Rheumatol 29:2521-2524,
2002.
23. Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I, Wolfe F.
Evidence from clinical trials and long-term observational studies that
disease-modifying anti-rheumatic drugs slow radiographic progression in
rheumatoid arthritis: updating a 1983 review. Rheumatology 41:1346-1356,
2002.
22. Pincus T, Sokka T. Partial control of Core data Set measures and
Disease Activity Score (DAS) measures of inflammation does not prevent
long-term joint damage: evidence from longitudinal observations over 5-20
years. Clin Exp Rheumatology 20 (Suppl.27): S42-S47, 2002.
21. Sokka T. Reactive Arthritis, In: Physician’s Information and Education
Resource (PIER), Philadelphia, PA: American College of Physicians –
American Society of Internal Medicine, 2002.
20. Pincus T, Sokka T, Stein M. Are long-term very low-doses of prednisone
for patients with rheumatoid arthritis as helpful as high doses are
harmful? Ann Intern Med 136:76-78, 2002.
2001

19. Pincus T, Sokka T. Quantitative Target Values of Predictors of
Mortality in Rheumatoid Arthritis as Possible Goals for Therapeutic
Interventions: an Alternative Approach to Remission or ACR20 Responses? J
Rheumatol 28:1723-1734, 2001.
18. Sokka T, Pincus T. Markers for Work Disability in Rheumatoid
Arthritis. J Rheumatol 28:1718-1722, 2001.
17. Pincus T, Sokka T, Wolfe F. Premature Mortality in patients with RA:
Evolving Concepts. Arthritis Rheum 44:1234-1236, 2001. (Editorial)
16. Pincus T, Sokka T. How can the risk of long-term consequences of
rheumatoid arthritis be reduced?
Best Practice & Research Clinical Rheumatology 15:139-170, 2001.
15. Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, Luta G,
Callahan LF, Wang X, Schwartz T, Abramson SB, Caldwell JR, Harrell RA,
Kremer JM, Lautzenheiser RL, Markenson JA, Schnizer TJ, Weaver A, Cummins
P, Wilson A, Morant S, Fort J. A randomized double blind crossover
clinical trial to compare diclofenac + misoprostol versus acetaminophen in
patients with osteoarthritis of the hip or knee. Arthritis Rheum
44:1587-1598, 2001.
14. Häkkinen A, Sokka T, Kotaniemi A, Hannonen P. A randomized two-year
study of the effects of dynamic strength training on muscle strength,
disease activity, functional capacity and bone mineral density in early
rheumatoid arthritis. Arthritis Rheum 44:515-522, 2001.
2000

13. Sokka T, Kankainen A, Hannonen P. Scores for functional disability in
patients with rheumatoid arthritis are correlated at higher levels with
pain scores than with radiographic scores. Arthritis Rheum 43:386-389,
2000.
12. Sokka T, Hannonen P. Healing of erosions in rheumatoid arthritis. Ann
Rheum Dis 59:647-649, 2000.
11. Sokka T, Möttönen T, Hannonen P. Disease-modifying anti-rheumatic drug
use according to the “sawtooth” treatment strategy improves the functional
outcome in rheumatoid arthritis: results of a long-term follow-up study
with review of the literature. Rheumatology 39:34-42, 2000.
1999

10. Sokka T. Extensive use of antirheumatic drugs improves long-term
outcomes in patients with rheumatoid arthritis. Kuopio University
Publications D. URL-address: www.uku.fi/tutkimus/vaitokset/1999. Doctoral
Thesis.
9. Sokka T, Möttönen T, Hannonen P. Mortality in early “sawtooth” treated
rheumatoid arthritis patients during the first 8-14 years. Scand J
Rheumatol 28:282-287, 1999.
8. Sokka T, Kaarela K, Möttönen T, Hannonen P. Conventional monotherapy
compared to a “sawtooth” treatment strategy in the radiographic
progression of rheumatoid arthritis over the first eight years. Clinic Exp
Rheumatol 17:527-532, 1999.
7. Sokka T, Hannonen P. Utility of disease modifying antirheumatic drugs
in “sawtooth” strategy. A prospective study of early rheumatoid arthritis
patients up to 15 years. Ann Rheum Dis 58:618-622, 1999.
6. Sokka T, Kautiainen H, Möttönen T, Hannonen P. Work disability in
rheumatoid arthritis 10 years after the diagnosis. J Rheumatol
26:1681-1685, 1999.
5. Häkkinen A, Sokka T, Kotaniemi A, Kautiainen H, Jäppinen I, Laitinen L,
Hannonen P. Dynamic strength training in patients with early rheumatoid
arthritis increases muscle strength but not bone mineral density. J
Rheumatol 26:1257-1263, 1999.
4. Häkkinen A, Sokka T, Kotaniemi A, Paananen ML, Mälkiä E, Kautiainen H,
Hannonen P. Muscle strength characteristics and central bone mineral
density in women with recent onset rheumatoid arthritis compared with
healthy controls. Scand J Rheumatol 28:145-151, 1999.
1998

3. Voutilainen M, Sokka T, Juhola M, Färkkila M, Hannonen P. Nonsteroidal
anti-inflammatory drug-associated upper gastrointestinal lesions in
rheumatoid arthritis patients. Relationships to gastric histology,
Helicobacter pylori infection, and other risk factors for peptic ulcer.
Scand J Gastroenterol 33:811-816, 1998.
2. Häkkinen A, Mälkiä E, Sokka T, Hannonen P. A physically demanding
occupation predicts premature retirement among patients with erosive
arthritis. Physiotherapy Theory and Practice 14;13-22, 1998.
1997

1. Sokka TM, Kautiainen HJ, Hannonen PJ. A retrospective study of treating
RA patients with various combinations of slow-acting antirheumatic drugs
in a county hospital. Scand J Rheumatol 26:440-443, 1997.

Source: http://www.tuulikkisokka.fi/myUploadData/files/TS%20All%20Publications.pdf